Please login to the form below

Not currently logged in

Drug supply chain

This page shows the latest Drug supply chain news and features for those working in and with pharma, biotech and healthcare.

EMA to consider coronavirus' impact on EU medicines supply

EMA to consider coronavirus' impact on EU medicines supply

The European Medicine Agency (EMA) has organised the first meeting of an executive steering group, which will address the potential impact of the novel coronavirus on the medicine supply chain in ... The US Food and Drug Administration has also said it

Latest news

More from news
Approximately 2 fully matching, plus 13 partially matching documents found.

Latest Intelligence

  • How can virtual pharma companies de-risk new product launches? How can virtual pharma companies de-risk new product launches?

    through to marketing, supply chain design, sales, distribution and other post- launch activities. ... USA, regulated by the Drug Supply Chain Security Act (DSCSA).

  • Emerging use cases of blockchain in healthcare and the life sciences

    Current processes that permit drug provenance and supply chain tracking are fragmented due to data silos, which can lead to human errors and fraud such as drug counterfeiting. ... Another example is the MediLedger Project, which brings together a

  • The logistics of orphan drugs The logistics of orphan drugs

    In many cases, the patient is in dire need of the drug and so the supply chain must operate at a much more rapid pace. ... When managing global access programmes it is important to maintain complete visibility of all steps in the supply chain along with

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Securing a future for telehealth with immersive market research insights...